ATE169227T1 - Hemmung von gefässverengung unter verwendung von anti-padgem antikörpern. - Google Patents

Hemmung von gefässverengung unter verwendung von anti-padgem antikörpern.

Info

Publication number
ATE169227T1
ATE169227T1 AT92922039T AT92922039T ATE169227T1 AT E169227 T1 ATE169227 T1 AT E169227T1 AT 92922039 T AT92922039 T AT 92922039T AT 92922039 T AT92922039 T AT 92922039T AT E169227 T1 ATE169227 T1 AT E169227T1
Authority
AT
Austria
Prior art keywords
padgem
vaso
contraction
inhibition
intravascular
Prior art date
Application number
AT92922039T
Other languages
English (en)
Inventor
Theresa M Palabrica
Bruce E Furie
Barbara C Furie
Roy R Lobb
Christopher D Benjamin
Original Assignee
Biogen Inc
New England Medical Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Inc, New England Medical Center Inc filed Critical Biogen Inc
Application granted granted Critical
Publication of ATE169227T1 publication Critical patent/ATE169227T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2851—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
    • C07K16/2854—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72 against selectins, e.g. CD62
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT92922039T 1991-09-30 1992-09-30 Hemmung von gefässverengung unter verwendung von anti-padgem antikörpern. ATE169227T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76883491A 1991-09-30 1991-09-30

Publications (1)

Publication Number Publication Date
ATE169227T1 true ATE169227T1 (de) 1998-08-15

Family

ID=25083621

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92922039T ATE169227T1 (de) 1991-09-30 1992-09-30 Hemmung von gefässverengung unter verwendung von anti-padgem antikörpern.

Country Status (9)

Country Link
EP (1) EP0606391B1 (de)
JP (1) JPH07502726A (de)
AT (1) ATE169227T1 (de)
AU (1) AU678757B2 (de)
CA (1) CA2120240A1 (de)
DE (1) DE69226531T2 (de)
DK (1) DK0606391T3 (de)
ES (1) ES2123010T3 (de)
WO (1) WO1993006863A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770198A (en) * 1988-05-18 1998-06-23 The Research Foundation Of The State Of New York Platelet-specific chimeric 7E3 immunoglobulin
AU2305201A (en) * 1993-11-05 2001-05-03 Centocor Inc. Platelet-specific chimeric immunoglobulin and methods of use therefor
WO1995012412A1 (en) * 1993-11-05 1995-05-11 Centocor, Inc. Platelet-specific chimeric immunoglobulin and methods of use therefor
EP1714661A3 (de) * 2000-05-19 2012-03-14 The Center for Blood Research, INC. Verfahren zur Diagnose und Behandlung von hämostatischen Störungen durch Modulation der P-Selectin Aktivität
EP1289552B1 (de) 2000-05-19 2006-03-29 The Center for Blood Research, INC. VERFAHREN ZUR BEHANDLUNG VON HÄMOSTATISCHEN STÖRUNGEN DURCH LöSLICHES P-SELECTIN
WO2005100402A1 (en) 2004-04-13 2005-10-27 F.Hoffmann-La Roche Ag Anti-p-selectin antibodies
PL2662091T3 (pl) 2006-12-01 2019-05-31 Novartis Ag Przeciwciała skierowane przeciwko selektynie P i sposoby ich zastosowania do leczenia chorób zapalnych
US20110212096A1 (en) 2006-12-01 2011-09-01 Scott Rollins Anti-p-selectin antibodies and methods of their use and identification
US8945565B2 (en) 2006-12-01 2015-02-03 Selexys Pharmaceuticals Corporation Methods of treating inflammatory or thrombotic conditions with anti-P-selectin antibodies
PE20110302A1 (es) 2008-09-19 2011-05-21 Hoffmann La Roche Formulacion farmaceutica de un anticuerpo contra p-selectina
US20200087403A1 (en) 2017-03-15 2020-03-19 INSERM (Institut National de la Santé et de la Recherche Médicale) Pharmaceutical compositions for the treatment of thrombosis in patients suffering from a myeloproliferative neoplasm
ES2911600T3 (es) 2017-06-20 2022-05-20 Inst Nat Sante Rech Med Métodos para identificar si pacientes con insuficiencia cardiaca aguda descompensada (ICAD) presentan un estado hipercoagulable

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991001380A1 (fr) * 1989-07-25 1991-02-07 Institut National De La Sante Et De La Recherche Medicale Anticorps monoclonaux diriges contre des proteines impliquees dans les fonctions plaquettaires, leur application en tant qu'agent diagnostique et therapeutique
JPH05504470A (ja) * 1989-10-20 1993-07-15 ニューイングランド・メディカル・センター・ホスピタルズ・インコーポレーテッド Ｐａｄｇｅｍを介した細胞結合の阻害
WO1991007993A1 (en) * 1989-11-30 1991-06-13 Mathew Vadas Anti-inflammatory and anti-adhesive factors

Also Published As

Publication number Publication date
JPH07502726A (ja) 1995-03-23
EP0606391A1 (de) 1994-07-20
AU678757B2 (en) 1997-06-12
DK0606391T3 (da) 1999-05-03
ES2123010T3 (es) 1999-01-01
EP0606391B1 (de) 1998-08-05
CA2120240A1 (en) 1993-03-31
WO1993006863A1 (en) 1993-04-15
DE69226531D1 (de) 1998-09-10
DE69226531T2 (de) 1999-05-06
AU2869492A (en) 1993-05-03

Similar Documents

Publication Publication Date Title
DE69226531D1 (de) Hemmung von Gefässverengung unter Verwendung von anti-PADGEM Antikörpern.
DK0603305T3 (da) Anvendelse af et thymosin til behandling af hepatitis C
ATE204480T1 (de) Monoklonaler antikörper, welcher spezifisch an vaskularisiertes tumorendothelium bindet und verwendungen davon
DE69227396D1 (de) Gefässimplantat mit Verzweigung
FI960374A7 (fi) Verisuoniendoteelikasvutekijän ilmestymisen estäminen antisenseoligonu kleotideilla
FI943635L (fi) Ihmisen interleukiini-5:n vastaisten humanisoitujen monoklonaalisten vasta-aineiden suunnittelu, kloonaus ja ekspressio
DE69220355D1 (de) Selbstausspreizbare, vaskuläre Endoprothese
ITTO930940A0 (it) Innesto protesico vascolare
BR9610447B1 (pt) Método para formar fibras artificiais de uma resina liquefeita.
FR2712466B1 (fr) Lacet de chaussure résistant au glissement, et son procédé de fabrication.
ATE196849T1 (de) Verfahren zur behandlung von multiplesklerose
DE68926342D1 (de) Verfahren zur herstellung von polyäthylenfilm mit ultrahohem molekylargewicht.
ATE166230T1 (de) Verwendung von anti-icam antikörpern zur herstellung eines präparats für die behandlung von endotoxinschock
IT8967343A0 (it) Anticorpo umano monoclonale ed ibridoma che produce il medesimo
ATE288280T1 (de) Verfahren zum blokieren von sec-rezeptoren
DE69615843D1 (de) Il-8 antagonisten zur behandlung von asthma
GB0031448D0 (en) Inhibition of the vWF-collagen interaction by anti-human vWF monoclonal antibody (82D6A3) results in abolition of in vivo arterial platelet thrombus formation
RU96119386A (ru) Антифибриновое антитело для применение в качестве противотромботического средства
ATE185969T1 (de) Potenzierung von nmda-antagonisten
DK0686044T3 (da) Hæmning af intimal hyperplasi under anvendelse af antistoffer mod PDGF-receptorer
NO973081L (no) Fremgangsmåte for behandling av kroniske progressive vaskulære sykdommer
FI922551A0 (fi) Foerfarande foer skoetsel av septisk chock.
RU96112183A (ru) Тромбоцит - специфичный химерный иммуноглобулин и методы его использования
NO922626L (no) Fremgangsmaate til fremstilling av lysozym-dimerer
UA37249C2 (uk) Спосіб інгібування стенозу та/або рестенозу (варіанти), спосіб інгібування рестенозу після проведення операції на коронарній артерії у людини (варіанти), спосіб зниження ймовірності виникнення чи запобігання негострих ішемічних ускладнень при ангіопластиці у людини

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee